Publications

Publications and pre-prints in reversed chronological order.

2024

  1. Diverse mutant selection windows shape spatial heterogeneity in evolving populations
    Eshan S King, Dagim S Tadele, Beck Pierce, and 2 more authors
    PLOS Computational Biology, 2024
  2. Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data
    Chenyu Wu, Einar Bjarki Gunnarsson, Even Moa Myklebust, and 6 more authors
    PLOS Computational Biology, 2024
  3. Frequency-dependent ecological interactions increase the prevalence, and shape the distribution, of preexisting drug resistance
    Jeff Maltas, Dagim Shiferaw Tadele, Arda Durmaz, and 3 more authors
    PRX Life, 2024
  4. Cell-Cell Fusion in Cancer: The Next Cancer Hallmark?
    Paulameena V Shultes, Davis T Weaver, Dagim S Tadele, and 2 more authors
    The International Journal of Biochemistry & Cell Biology, 2024

2023

  1. Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
    Alvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, and 8 more authors
    Cell Reports Methods, 2023
  2. Spatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems
    Sara Hamis, Panu Somervuo, J Arvid Ågren, and 7 more authors
    Journal of mathematical biology, 2023
  3. Maintaining, masking, and mimicking selection: the interplay of cell-intrinsic and cell-extrinsic effects upon eco-evolutionary dynamics
    Rowan Barker-Clarke, Jason M Gray, Dagim Shiferaw Tadele, and 2 more authors
    bioRxiv, 2023
  4. Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, and 8 more authors
    Nature communications, 2023

2021

  1. A cell competition–based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
    Dagim Shiferaw Tadele, Joseph Robertson, Richard Crispin, and 8 more authors
    Journal of Biological Chemistry, 2021

2017

  1. Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response
    Sandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, and 7 more authors
    Breast Cancer: Targets and Therapy, 2017